What is the recommended levosalbutamol nebulisation regimen for a child presenting with an acute asthma exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levosalbutamol Nebulisation for Acute Pediatric Asthma Exacerbation

For a child with acute asthma exacerbation, administer levosalbutamol 0.075 mg/kg per dose (minimum 1.25 mg) via oxygen-driven nebulizer every 20 minutes for three consecutive doses in the first hour, then continue at 0.075–0.15 mg/kg every 1–4 hours based on clinical response. 1

Initial Intensive Phase (First Hour)

  • Give levosalbutamol 0.075 mg/kg per dose (minimum 1.25 mg, practical maximum 1.25 mg for most children) via oxygen-driven nebulizer every 20 minutes for three doses during the first hour of presentation 1

  • This weight-based regimen provides approximately half the milligram dose of racemic salbutamol while achieving comparable bronchodilation 1

  • For children ≤2 years or <15 kg, use the minimum dose of 1.25 mg per nebulization 1

  • Deliver via oxygen-driven nebulizer to maintain SpO₂ >92% throughout treatment 2, 1

Concurrent Essential Therapy

  • Administer oral prednisolone 1–2 mg/kg (maximum 40–60 mg) immediately upon recognition of the exacerbation; if the child is vomiting or critically ill, give IV hydrocortisone 100 mg every 6 hours 1, 3

  • Add ipratropium bromide 100–250 µg to each nebulizer treatment for moderate-to-severe attacks; repeat every 6 hours until improvement begins 2, 1

  • Provide high-flow oxygen via face mask to maintain SpO₂ >92% 2, 1

Reassessment at 15–30 Minutes

  • Measure peak expiratory flow (if age ≥5 years), respiratory rate, heart rate, and SpO₂ after the initial intensive phase 1

Response-Guided Continuation

  • Good response (PEF >75% predicted, minimal symptoms): continue levosalbutamol 0.075–0.15 mg/kg every 4 hours as needed, maintain controller therapy, arrange follow-up within 48 hours 1

  • Incomplete response (PEF 50–75% predicted, persistent symptoms): continue levosalbutamol every 4 hours, maintain oxygen and prednisolone, consider hospital admission 1

  • Poor response (PEF <50% predicted or ongoing severe features): increase levosalbutamol frequency to every 15–30 minutes or switch to continuous nebulization at the same per-dose amount, continue ipratropium every 6 hours, arrange immediate admission 1

Evidence Base for Levosalbutamol

  • International pediatric asthma guidelines (British Thoracic Society, Global Initiative for Asthma) recommend racemic salbutamol as the standard bronchodilator for acute attacks 2, 1

  • Small comparative studies suggest levosalbutamol may yield modestly better SpO₂, PEFR, and asthma scores with less tachycardia and hypokalemia compared to racemic salbutamol 4, 5, though one ED study found no difference 6

  • The evidence for levosalbutamol superiority is limited and not incorporated into major guidelines; if chosen, apply the same escalation protocol described for standard salbutamol 1

Safety Monitoring

  • When levosalbutamol is given at higher doses or frequent intervals, monitor for tachycardia, tremor, and hypokalemia as expected adverse effects 1

  • Levosalbutamol appears to cause less tachycardia and less hypokalemia than racemic salbutamol at equivalent bronchodilator doses 4, 5

Hospital Admission Criteria

  • Admit immediately for any life-threatening feature (PEF <33% predicted, silent chest, cyanosis, poor respiratory effort, altered consciousness, SpO₂ <92% despite oxygen) 2, 1

  • Admit for persistent severe attack after initial therapy, PEF <50% after 1–2 hours of intensive treatment, inability of caregivers to manage at home, or early deterioration after bronchodilators 1

  • Apply a lower threshold for admission for evening presentations, recent nocturnal symptoms, prior severe attacks, or poor social support 2, 1

Critical Pitfalls to Avoid

  • Never delay systemic corticosteroids while giving repeated bronchodilator doses alone—this is a common cause of treatment failure and preventable mortality 1, 3

  • Do not give an aminophylline bolus to children already receiving oral theophylline 2, 1

  • Sedatives are absolutely contraindicated in acute pediatric asthma 1

  • Do not rely solely on subjective assessment—obtain objective measurements (PEF if age-appropriate, SpO₂) to guide escalation 2, 1

Escalation for Refractory Cases

  • If no improvement after the first reassessment, increase levosalbutamol frequency to every 15–30 minutes or switch to continuous nebulization, ensure ipratropium is added, and continue oxygen and systemic steroids 1

  • For life-threatening deterioration, give IV aminophylline 5 mg/kg over 20 minutes followed by maintenance infusion of 1 mg/kg/hour; prepare for ICU transfer 2, 1

References

Guideline

Acute Pediatric Asthma Exacerbation – Evidence‑Based Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended levosalbutamol nebuliser dose and maximum dose for children with an acute asthma exacerbation?
What is the recommended levosalbutamol nebuliser dose, administration method, contraindications, monitoring, and escalation for a child with an acute asthma exacerbation?
What is the recommended frequency of salbutamol (albuterol) nebule administration for pediatric patients with a cough and a history of asthma?
What is the recommended dose of salbutamol (albuterol) syrup for a 7-year-old child weighing 22kg?
What is the recommended dose of salbutamol (albuterol) for nebulization in a 1-year-old child?
What is the recommended emergency management of an acute intracerebral hemorrhage, including airway stabilization, blood pressure control, anticoagulant reversal, emergent neuroimaging, surgical indications, intensive care measures, and secondary prevention?
Should a patient with cerebral venous sinus thrombosis due to antiphospholipid syndrome (positive anti‑cardiolipin antibodies) who has been treated with warfarin for six months and has only partial sinus recanalization continue anticoagulation indefinitely?
What are the acute, intermediate (sub‑acute), and chronic clinical presentations of osmotic demyelination syndrome?
How do acute cholecystitis and chronic cholecystitis differ in presentation and management?
What is the appropriate indication, dosage, and duration of Neurobion Forte (high‑strength B‑complex: thiamine 100 mg, pyridoxine 100 mg, cyanocobalamin 500 µg) for an adult with suspected vitamin B1, B6 or B12 deficiency or peripheral neuropathy?
Is the hair porosity test evidence‑based?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.